MedTrace Logo

Propofol or Midazolam for Sedation and Early Extubation Following Coronary Artery Bypass Graft Surgery

NCT05290324 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-03-22

No results posted yet for this study

Summary

Propofol and midazolam are used frequently as sedating agents among patients who undergo coronary artery bypass graft surgery but no study in Pakistan has been done to compare their effectiveness aiming early extubation.

Conditions

Interventions

DRUG

Midazolam

Midazolam infusion will be given after the surgery as 0.25 mg/kg/min.

Sponsors & Collaborators

  • Chaudhry Pervaiz Elahi Institute of Cardiology

    lead OTHER_GOV

Principal Investigators

  • Shumaila Rai, MBBS · Ch. Pervaiz Elahi Institute of Cardiology, Multan, Pakisan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-02-01
Completion
2020-02-01

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05290324 on ClinicalTrials.gov